Primary Care Clinics in Wiley, CO Accepting Medicare
3 Primary Care Clinics found. Showing 1 - 3
 Wiley Medical Clinic Clinic/Center Medicare: Not Enrolled in Medicare Practice Location: 302 Main St, Wiley, CO 81092 Phone: 719-829-4627 Fax: 719-829-4269 |
Wiley Medical Clinic Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 302 Main, Wiley, CO 81092 Phone: 719-829-4627 Fax: 719-829-4269 |
High Plains Wiley Clinic Clinic/Center - Federally Qualified Health Center (FQHC) Medicare: Medicare Enrolled Practice Location: 302 Main, Wiley, CO 81092 Phone: 719-829-4286 Fax: 719-829-4288 |
News Archive
Ventas to deliver presentation at NAREIT REITWeek 2014 Conference, New York
Ventas, Inc. ("Ventas" or the "Company") announced today that management will make a presentation regarding the Company at the NAREIT REITWeek 2014 Conference in New York, New York on Wednesday, June 4, 2014, at 3:45 p.m. Eastern Time.
BioInvent, ThromboGenics initiate TB-402 Phase IIb trial for VTE prophylaxis
ThromboGenics NV and co-development partner BioInvent International announce today that the first patient has been dosed in a Phase IIb trial with their novel long-acting anticoagulant TB-402 for the prophylaxis of venous thromboembolism after total hip surgery.
Children's oral language can be a good predictor of future writing difficulties
Children's future writing difficulties can be identified before they even learn how to begin writing, according to a new study by Professor Phaedra Royle and Postdoctoral fellow Alexandra Marquis of the University of Montreal's School of Speech Language Pathology and Audiology.
Every second counts when performing cardiac arrest resuscitation
A new study has found the number of people who survive after suffering a cardiac arrest outside a hospital drops significantly if the pause between stopping CPR and using a defibrillator to administer an electric shock is longer than 20 seconds.
NASDAQ issues delisting notice to Commonwealth Biotechnologies
On July 24, 2009, The NASDAQ Stock Market notified Commonwealth Biotechnologies, Inc. that CBI was to be delisted from the NASDAQ Capital Market as a result of a failure to comply with NASDAQ Listing Rule 5550(b) due to a failure to maintain minimum stockholders' equity of $2.5 million and a failure to file a Form 8-K affirming compliance with Rule 5550(b).
› Verified 3 days ago